Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-17

Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Evolve) [Phase 2]

View source ↗

Summary

This is a Phase 2 study (ACROBAT Evolve) assessing the safety and efficacy of Paltusotine for acromegaly; the trial completed and results were posted in 2025.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Paltusotine (paltusotine)

Snippet

Sponsor: Crinetics Pharmaceuticals Inc. | Conditions: Acromegaly | Phase 2 | Status: COMPLETED | Results posted: 2025-03-17